• Cognitive Effects Transient for Alzheimer's Drug Atabecestat

    One year ago - By Medscape

    A preliminary analysis found the 25 mg dose of the investigational AD drug atabecestat to significantly worsen subjects' cognition starting at around 3 months of treatment, compared with placebo.
    Medscape Medical News
    Read more ...